Synapse - Efsevia Vakiani

Results (103)

Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade

Meeting Abstract

Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Recurrent, truncating Sox9 mutations are associated with sox9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma

Journal Article

Javier, B. M.; Yaeger, R.; Wang, L.; Sanchez-Vega, F.; Zehir, A.; Middha, S.; Sadowska, J.; Vakiani, E.; Shia, J.; Klimstra, D.; more...
Oncotarget (2016)

Fulltext@MSK | Save

Clinical prognostic factors and genomic analysis of ovary metastases (mets) from colorectal cancer (CRC)

Meeting Abstract

Ganesh, K.; Shah, R.; Vakiani, E.; Kemeny, N. E.; Lincoln, A.; Tran, C.; Varghese, A. M.; Yaeger, R. D.; Cercek, A.; Segal, N. H.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Genomic profiling and efficacy of anti-EGFR therapy in appendiceal adenocarcinoma

Meeting Abstract

Braghiroli, M.; Nash, G. M.; Morris, M.; Hechtman, J. F.; Vakiani, E.; Berger, M. F.; Solit, D. B.; Saltz, L.; Cercek, A.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Identification of targetable kinase alterations in patients with colorectal carcinoma that are preferentially associated with wild-type RAS/RAF

Journal Article

Hechtman, J. F.; Zehir, A.; Yaeger, R.; Wang, L.; Middha, S.; Zheng, T.; Hyman, D. M.; Solit, D.; Arcila, M. E.; Borsu, L.; more...
Molecular Cancer Research (2016)

Fulltext@MSK | Save

Recurrent, truncating SOX9 mutations are associated with KRAS and PI3K pathway mutations and may be oncogenic in colorectal carcinoma

Meeting Abstract

Hechtman, J.; Javier, B. M.; Vakiani, E.; Shia, J.; Zehir, A.; Iacobuzio-Donahue, C.
Modern Pathology (2016)

Fulltext@MSK | Save

20q gain is an oncogenic driver event that occurs preferentially in KRAS/ BRAF wild type colorectal carcinoma

Meeting Abstract

Pagan, C.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Shia, J. R.; Vakiani, E.; Ladanyi, M.; Hechtman, J.
Modern Pathology (2016)

Fulltext@MSK | Save

Comprehensive morphological assessment of colorectal cancers characterized by The Cancer Genome Atlas (TCGA) identifies specific morphology-molecular alteration associations

Meeting Abstract

Shia, J. R.; Kuk, D.; Schultz, N.; Berger, M.; Middha, S.; Vakiani, E.; Hechtman, J.; Stadler, Z.; Weiser, M.; Gonen, M.; more...
Modern Pathology (2016)

Fulltext@MSK | Save

20q gain is an oncogenic driver event that occurs preferentially in KRAS/BRAF wild type colorectal carcinoma

Meeting Abstract

Pagan, C.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Shia, J.; Vakiani, E.; Ladanyi, M.; Hechtman, J.
Laboratory Investigation (2016)

Fulltext@MSK | Save

Recurrent, truncating SOX9 mutations are associated with KRAS and PI3K pathway mutations and may be oncogenic in colorectal carcinoma

Meeting Abstract

Hechtman, J.; Javier, B. M.; Vakiani, E.; Shia, J.; Zehir, A.; Iacobuzio-Donahue, C.
Laboratory Investigation (2016)

Fulltext@MSK | Save